C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
11/2002
11/13/2002	EP1255543A2 Use of retinoid-type compounds as antibacterial agents
11/13/2002	EP0973760B1 Kodaistatins a, b, c and d, a process for their production and their use
11/13/2002	CN1379755A Substituted 2-dialkylamino alkylbiphenyl derivatives
11/13/2002	CN1379754A Intermediates for making benzofuran or benzothiophene derivative nitrated in position 5 and uses thereof
11/13/2002	CN1379752A Aromatic di-ceto-derivatives use as glucose-6-phosphate translocase inhibitors
11/13/2002	CN1379748A Process for preparing optically active alpha-hydroxy acids and derivatives thereof
11/13/2002	CN1379746A Process for simultaneous production of maleic anhydride and its hydrogenated derivatives
11/13/2002	CN1379669A Valdecoxib compositions
11/13/2002	CN1379666A Non-peptide GnRH agents, methods and intermediates for their preparation
11/13/2002	CN1379025A Process for preparing 5-cynophenyl phthaleine
11/13/2002	CN1094125C Process for preparing high purity carane aldehyde
11/13/2002	CN1094119C New synthesizing method of 2-(2-substituting ethyl) cyclohexanone
11/12/2002	US6479677 Processes for the preparation of 2-methylfuran and 2-methyltetrahydrofuran
11/12/2002	US6479675 Processes for preparing 3-(1-hydroxyphenyl-1-alkoximinomethyl) dioxazines
11/12/2002	US6479554 Immunotherapeutic agents
11/12/2002	US6479552 Use of substituted N, N-disubstituted diamino compounds for inhibiting cholesteryl ester transfer protein activity
11/12/2002	US6479550 α-sulfenimino acid derivatives
11/12/2002	US6479538 Cyclic ether vitamin D3 compounds, 1α(OH)3-EPI-vitamin D3 compounds and uses thereof
11/12/2002	US6479536 Benzofuran derivatives, process for the preparation of the same and uses thereof
11/12/2002	US6479524 To prolong the thrombin time
11/11/2002	CA2347879A1 Substituted dicinnamoylquinides and their use in augmentation of adenosine function
11/07/2002	WO2002088106A2 Cysteine protease inhibitors
11/07/2002	WO2002088073A1 Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof
11/07/2002	WO2002087566A1 The use of enantiomeric pure escitalopram
11/07/2002	US20020165416 Efficiently producing a compound having an alkyl group or alkenyl group bonded at the alpha position of an electron attractive group, by catalytic radical addition reaction with compound of Group 5,6,7,8, or 9
11/07/2002	US20020165403 Method for the preparation of 5-carboxyphthalide
11/07/2002	US20020165394 Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
11/07/2002	US20020165391 Novel spiro compounds
11/07/2002	US20020165255 Prostaglandin agonists such as (3-(methanesulfonylamino-methyl)-phenoxy)-acetic acid methyl ester for preventing/ restoring bone mass loss
11/07/2002	US20020165236 Such as 3-(3-(4-(4-sulfamoyl-benzylsulfamoyl-phenyl)-ureido)-benzamidine for treatment of malaria
11/07/2002	US20020165235 Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as IP antagonists
11/07/2002	US20020165232 Substituted N, N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
11/07/2002	US20020165231 Substituted N-heteroaryl-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
11/07/2002	US20020165230 Gamma-ketoacid dipeptides as inhibitors of caspase-3
11/07/2002	US20020165218 Mixture of kinase inhibitor and anticancer agents
11/07/2002	US20020165200 Central nervous system disorders
11/07/2002	US20020164577 Detection of transmembrane potentials by optical methods
11/07/2002	DE10214515A1 New curable compound is liquid state before curing and soften/liquefy in short time after curing at lower temperature than thermal decomposition point
11/07/2002	DE10121652A1 Verfahren zur Herstellung von 1,3-disubstituierten 2-Nitroguanidinen A process for the preparation of 1,3-disubstituted 2-nitroguanidines
11/07/2002	CA2445843A1 The use of enantiomeric pure escitalopram
11/07/2002	CA2429001A1 Cysteine protease inhibitors
11/06/2002	EP1254899A2 Piperazine derivatives and their use as anti-inflammatory agents
11/06/2002	EP1254895A1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same
11/06/2002	EP1254884A2 Preparation of vinyl ethers from alcohols and alkenes
11/06/2002	EP1254129A1 Method for the preparation of 5-cyanophthalide
11/06/2002	EP1254101A1 Propionic acid derivatives and their use in the treatment of diabetes and obesity
11/06/2002	EP1181097B1 Method of producing monolithic oxidation catalysts and their use in gas phase oxidation of carbohydrates
11/06/2002	EP1124788A4 Bis(haloethyl)aminobenzene derivatives
11/06/2002	EP1053232B1 Process for the preparation of sotolon
11/06/2002	EP0998280A4 Carbohydrate scaffold compounds and libraries
11/06/2002	EP0983219B1 Method for producing aliphatic alcohols
11/06/2002	EP0788473B1 Novel high enantio-selective process for producing pure enantiomeric cyclopentane and cyclopentene-beta-amino acids
11/06/2002	CN1378548A Method for separating analogous organic compounds
11/06/2002	CN1378527A Biaryl ether derivatives useful as monoamine reuptake inhibitors
11/06/2002	CN1377883A Cosmetic preparation containing light stable UV-A light filter agent
11/05/2002	US6476264 N-(4-carbamimidoyl-phenyl)-glycine derivatives
11/05/2002	US6476251 Process for preparing spirocyclic tetronic acid derivatives
11/05/2002	US6476239 Process for the preparation of ascorbic acid
11/05/2002	US6476238 Purification method for obtaining high-purity PMDA
11/05/2002	US6476075 Use of substituted N, N-bis-benzyl aminoalcohol compounds inhibiting cholesteryl ester transfer protein activity
11/05/2002	US6476057 Use of substituted N, N-disubstituted cycloalkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
11/05/2002	US6476026 Compounds and compositions as protease inhibitors
11/05/2002	US6476023 Aromatic heterocyclic compounds as anti-inflammatory agents
11/05/2002	US6475133 Methods for making 2-(ω-alkoxycarbonylalkanoyl)-4-butanolide, ester of omega-hydroxy-(ω-3)-ketoaliphatic acid, and derivatives thereof
11/05/2002	CA2359810C Process for the preparation of pure citalopram
11/05/2002	CA2038379C Trifluoromethyl mercaptan and mercaptoacyl derivatives and method of using same
11/05/2002	CA2038029C 1-alkyl-, 1-alkenyl- and 1-alkynylaryl-2-amino-1,3-propanediols and related compounds, a process and intermediates for their preparation and theeir use as medicaments
11/04/2002	WO2004001058A2 Transcription factor modulating compounds and methods of use thereof
10/2002
10/31/2002	WO2002085838A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/31/2002	WO2002085836A1 Binaphtol derivative and process for producing the same
10/31/2002	WO2002085834A1 Method for purifying an organic solvent for the purpose of absorption of maleic acid anhydride
10/31/2002	WO2002085833A1 Processes for preparation of optically active 2-benzyl- succinic acid and optically active 2-benzylsuccinic acid monoamides
10/31/2002	WO2002085829A1 Process for production of dimers of aromatic monohydroxyl compounds
10/31/2002	WO2002085301A2 Indole, azaindole and related heterocyclic amidopiperazine derivatives
10/31/2002	WO2002070499A3 Prodrugs derivatives of the ascorbic acid suitable to the passage of the hematoencephalic barrier
10/31/2002	WO2001070675A3 Inhibitors of histone deacetylase
10/31/2002	WO2001056563A9 Adamantyl derivatives as anti-cancer agents
10/31/2002	US20020161252 Zinc complex with a chiral ligand, such as diethylzinc((S,S)-N-N'-ethylene-bis-(1-phenylethylamine))
10/31/2002	US20020161244 Preparation of cis-6,6-dimethyl-3-oxa-bicyclo(3.1.0)hexan-2-one
10/31/2002	US20020161243 Method of gas phase catalytic oxidation to give maleic aicd anhydride
10/31/2002	US20020161237 (Z)-2-((2-bromo-4-(((3-hydroxybenzyl)amino)carbonyl)benzoyl) -amino)pent-2-enoic acid, for example; useful for treating psoriasis
10/31/2002	US20020161234 Forming a diastereoselective epoxide from a chiral alpha-amino aldehyde
10/31/2002	US20020161039 Crystalline choline ascorbate
10/31/2002	US20020160996 Benzofuran substituted by a fused nitrogen-containing heterocyclic ring such as isoindoline; inhibits cytotoxicity of beta-amyloid; Alzheimer's or Parkinson's disease
10/31/2002	US20020157192 4-amino-2-(1-aryloxy-ethyl)phenol compound
10/31/2002	CA2444804A1 Method for purifying an organic solvent for the purpose of absorption of maleic acid anhydride
10/30/2002	EP1253146A1 Process for the synthesis of substituted furancarboxylates
10/30/2002	EP1253138A2 Novel tertiary amine compounds having an ester structure and processes for preparing same
10/30/2002	EP1252139A1 Trifluoromethylpyrrole carboxamides and trifluoromethylpyrrolethioamides as fungicides
10/30/2002	EP1252138A2 A new process for the preparation of latanoprost
10/30/2002	EP1252133A2 Pharmaceutical compounds
10/30/2002	EP1251822A1 Novel coupler for use in oxidative hair dyeing
10/30/2002	EP1000172A4 Detection of targets with green fluorescent protein and fluorescent variants thereof
10/30/2002	EP0854863B1 Esters and amides as pla2 inhibitors
10/30/2002	CN1377342A Processes for the preparation of tricyclic amino alcohol derivatives
10/30/2002	CN1377336A Carboxylic acid derivatives and drugs containing the same
10/30/2002	CN1377268A Cell adhesion inhibitors
10/30/2002	CN1377263A Neuropathy improves containing nitrogenous compounds as the active ingredient
10/30/2002	CN1377259A ACE-2 inhibiting compounds and methods of use thereof
10/30/2002	CN1093539C Process for synthesizing beta-halobutenolide

1 ... 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 ... 472